Looks like a partial win to me. It's also good that they had the larger study population so that they had big enough numbers to see the statistical significance breakdown between those who got chemo and those who did not.
I think that we see the prices start to rebound back up some once the reality of that sinks in. Nothing has changed otherwise.
News 
Market Data 
Discover 
